메뉴 건너뛰기




Volumn 2, Issue SEP, 2011, Pages

Association of allelic variation in genes mediating aspects of energy homeostasis with weight gain during administration of antipsychotic drugs (CATIE study)

Author keywords

Antipsychotic drugs; Candidate genes; Catie study; Energy homeostasis; FTO gene; KCNJ11 gene; Schizophrenia; Weight gain

Indexed keywords


EID: 84862891057     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2011.00056     Document Type: Article
Times cited : (19)

References (48)
  • 1
    • 14644415476 scopus 로고    scopus 로고
    • Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs
    • Ader, M., Kim, S. P., Catalano, K. J., Ionut, V., Hucking, K., Richey, J. M., Kabir, M., and Bergman, R. N. (2005). Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease: a placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54, 862-871.
    • (2005) Diabetes , vol.54 , pp. 862-871
    • Ader, M.1    Kim, S.P.2    Catalano, K.J.3    Ionut, V.4    Hucking, K.5    Richey, J.M.6    Kabir, M.7    Bergman, R.N.8
  • 2
    • 0035041926 scopus 로고    scopus 로고
    • Antipsychotic-induced weight gain: a review of the literature
    • [Review]
    • Allison, D. B., and Casey, D. E. (2001). Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 62(Suppl. 7), 22-31. [Review].
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 7 , pp. 22-31
    • Allison, D.B.1    Casey, D.E.2
  • 5
    • 0842348094 scopus 로고    scopus 로고
    • Consensus development conference on antipsychotic drugs and obesity and diabetes
    • American Diabetes Association American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
    • American Diabetes Association American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596-601.
    • (2004) Diabetes Care , vol.27 , pp. 596-601
  • 6
    • 27644536615 scopus 로고    scopus 로고
    • Actions of antipsychotic drugs on pancreatic ß-cell function: contrasting effects of clozapine and haloperidol
    • Best, L., Yates, A. P., and Reynolds, G. P. (2005). Actions of antipsychotic drugs on pancreatic ß-cell function: contrasting effects of clozapine and haloperidol. J Psychopharmacol. 19, 597-601.
    • (2005) J Psychopharmacol , vol.19 , pp. 597-601
    • Best, L.1    Yates, A.P.2    Reynolds, G.P.3
  • 7
    • 34247542475 scopus 로고    scopus 로고
    • Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia
    • Brecher, M., Leong, R. W., Stening, G., Osterling-Koskinen, L., and Jones, A. M. (2007). Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia. J. Clin. psychiatry 68, 597.
    • (2007) J. Clin. psychiatry , vol.68 , pp. 597
    • Brecher, M.1    Leong, R.W.2    Stening, G.3    Osterling-Koskinen, L.4    Jones, A.M.5
  • 8
    • 4344665860 scopus 로고    scopus 로고
    • Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules
    • Chimienti, F., Devergnas, S., Favier, A., and Seve, M. (2004). Identification and cloning of a beta-cell-specific zinc transporter, ZnT-8, localized into insulin secretory granules. Diabetes 53, 2330-2337.
    • (2004) Diabetes , vol.53 , pp. 2330-2337
    • Chimienti, F.1    Devergnas, S.2    Favier, A.3    Seve, M.4
  • 9
    • 84875953141 scopus 로고    scopus 로고
    • Energy and metabolism and obesity: research and clinical applications
    • ed. P. Donohoue (New Jersey: Humana Press)
    • Chung, W. K., and Leibel, R. L. (2008). "Energy and metabolism and obesity: research and clinical applications," in Molecular Physiology of Monogenic and Syndromic Obesities in Human, ed. P. Donohoue (New Jersey: Humana Press), 1-22.
    • (2008) Molecular Physiology of Monogenic and Syndromic Obesities in Human , pp. 1-22
    • Chung, W.K.1    Leibel, R.L.2
  • 10
    • 79957794555 scopus 로고    scopus 로고
    • Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder
    • Citrome, L., Holt, R. I., Walker, D. J., and Hoffmann, V. P. (2011). Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. Clin. Drug Investig. 31, 455-482.
    • (2011) Clin. Drug Investig. , vol.31 , pp. 455-482
    • Citrome, L.1    Holt, R.I.2    Walker, D.J.3    Hoffmann, V.P.4
  • 12
    • 70350738289 scopus 로고    scopus 로고
    • Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
    • Erratum in: JAMA 302 2322
    • Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., and Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302, 1765-1773; Erratum in: JAMA 302, 2322.
    • (2009) JAMA , vol.302 , pp. 1765-1773
    • Correll, C.U.1    Manu, P.2    Olshanskiy, V.3    Napolitano, B.4    Kane, J.M.5    Malhotra, A.K.6
  • 15
    • 0242524453 scopus 로고    scopus 로고
    • The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits
    • Florez, J. C., Hirschhorn, J., and Altshuler, D. (2003). The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu. Rev. Genomics Hum. Genet. 4, 257-291.
    • (2003) Annu. Rev. Genomics Hum. Genet. , vol.4 , pp. 257-291
    • Florez, J.C.1    Hirschhorn, J.2    Altshuler, D.3
  • 17
    • 43249090541 scopus 로고    scopus 로고
    • A multiple testing correction for genetic association studies using correlated single nucleotide polymorphisms
    • Gao, X., Starmer, J., and Martin, E. (2008). A multiple testing correction for genetic association studies using correlated single nucleotide polymorphisms. Genet. Epidemiol. 21, 361-369.
    • (2008) Genet. Epidemiol. , vol.21 , pp. 361-369
    • Gao, X.1    Starmer, J.2    Martin, E.3
  • 19
    • 33645473668 scopus 로고    scopus 로고
    • Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis
    • [Review]
    • Gentile, S. (2006). Long-term treatment with atypical antipsychotics and the risk of weight gain: a literature analysis. Drug Saf. 29, 303-319. [Review].
    • (2006) Drug Saf , vol.29 , pp. 303-319
    • Gentile, S.1
  • 20
    • 33646103388 scopus 로고    scopus 로고
    • Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J
    • Gough, S. C., and O'Donovan, M. C. (2005). Clustering of metabolic comorbidity in schizophrenia: a genetic contribution? J. Psychopharmacol. 19(6 Suppl.), 47-55.
    • (2005) Psychopharmacol , vol.19 , Issue.6 SUPPL. , pp. 47-55
    • Gough, S.C.1    O'Donovan, M.C.2
  • 21
    • 77951623073 scopus 로고    scopus 로고
    • Crystal structure of the FTO protein reveals basis for its substrate specificity
    • Han, Z., Niu, T., Chang, J., Lei, X., Zhao, M., Wang, Q., Cheng, W., Wang, J., Feng, Y., and Chai, J. (2010). Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464, 1205-1209.
    • (2010) Nature , vol.464 , pp. 1205-1209
    • Han, Z.1    Niu, T.2    Chang, J.3    Lei, X.4    Zhao, M.5    Wang, Q.6    Cheng, W.7    Wang, J.8    Feng, Y.9    Chai, J.10
  • 22
    • 33646001081 scopus 로고    scopus 로고
    • Association between antipsychotic drugs and diabetes
    • Holt, R. I., and Peveler, R. C. (2006). Association between antipsychotic drugs and diabetes. Diabetes Obes. Metab. 8, 125-135.
    • (2006) Diabetes Obes. Metab. , vol.8 , pp. 125-135
    • Holt, R.I.1    Peveler, R.C.2
  • 25
    • 0038220770 scopus 로고    scopus 로고
    • Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes
    • Lean, M. E., and Pajonk, F. G. (2003). Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetes Care 26, 1597-1605.
    • (2003) Diabetes Care , vol.26 , pp. 1597-1605
    • Lean, M.E.1    Pajonk, F.G.2
  • 27
    • 39749123292 scopus 로고    scopus 로고
    • Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity
    • Lindgren, C. M., and McCarthy, M. I. (2008). Mechanisms of disease: genetic insights into the etiology of type 2 diabetes and obesity. Nat. Clin. Pract. Endocrinol. Metab. 4, 156-163.
    • (2008) Nat. Clin. Pract. Endocrinol. Metab. , vol.4 , pp. 156-163
    • Lindgren, C.M.1    McCarthy, M.I.2
  • 29
    • 0344609217 scopus 로고    scopus 로고
    • Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus
    • Mäkimattila, S., Nikkilä, K., and Yki-Järvinen, H. (1999). Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 42, 406-412.
    • (1999) Diabetologia , vol.42 , pp. 406-412
    • Mäkimattila, S.1    Nikkilä, K.2    Yki-Järvinen, H.3
  • 30
    • 78649842241 scopus 로고    scopus 로고
    • Genomics, type 2 diabetes, and obesity
    • McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. N. Engl. J. Med. 363, 2339-2350.
    • (2010) N. Engl. J. Med. , vol.363 , pp. 2339-2350
    • McCarthy, M.I.1
  • 34
    • 4344634394 scopus 로고    scopus 로고
    • A simple significance test for quantile regression
    • Redden, D. T., Fernández, J. R., and Allison, D. B. (2004). A simple significance test for quantile regression. Stat. Med. 23, 2587-2597.
    • (2004) Stat. Med. , vol.23 , pp. 2587-2597
    • Redden, D.T.1    Fernández, J.R.2    Allison, D.B.3
  • 37
    • 0031440266 scopus 로고    scopus 로고
    • Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
    • Spanswick, D., Smith, M. A., Groppi, V. E., Logan, S. D., and Ashford, M. L. (1997). Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 390, 521-525.
    • (1997) Nature , vol.390 , pp. 521-525
    • Spanswick, D.1    Smith, M.A.2    Groppi, V.E.3    Logan, S.D.4    Ashford, M.L.5
  • 39
    • 34249331312 scopus 로고    scopus 로고
    • Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons
    • Strassnig, M., Miewald, J., Keshavan, M., and Ganguli, R. (2007). Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons. Schizophr. Res. 93, 90-98.
    • (2007) Schizophr. Res. , vol.93 , pp. 90-98
    • Strassnig, M.1    Miewald, J.2    Keshavan, M.3    Ganguli, R.4
  • 40
    • 78649464259 scopus 로고    scopus 로고
    • Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling
    • Stratigopoulos, G., LeDuc, C. A., Cremona, M. L., Chung, W. K., and Leibel, R. L. (2011). Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J. Biol. Chem. 286, 2155-2170.
    • (2011) J. Biol. Chem. , vol.286 , pp. 2155-2170
    • Stratigopoulos, G.1    LeDuc, C.A.2    Cremona, M.L.3    Chung, W.K.4    Leibel, R.L.5
  • 42
    • 0038448311 scopus 로고    scopus 로고
    • The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development
    • Stroup, T. S., McEvoy, J. P., Swartz, M. S., Byerly, M. J., Glick, I. D., Canive, J. M., McGee, M. F., Simpson, G. M., Stevens, M. C., and Lieberman, J. A. (2003). The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 29, 15-31.
    • (2003) Schizophr Bull , vol.29 , pp. 15-31
    • Stroup, T.S.1    McEvoy, J.P.2    Swartz, M.S.3    Byerly, M.J.4    Glick, I.D.5    Canive, J.M.6    McGee, M.F.7    Simpson, G.M.8    Stevens, M.C.9    Lieberman, J.A.10
  • 44
    • 70350742943 scopus 로고    scopus 로고
    • Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents
    • Varley, C. K., and McClellan, J. (2009). Implications of marked weight gain associated with atypical antipsychotic medications in children and adolescents. JAMA 302, 1811-1812.
    • (2009) JAMA , vol.302 , pp. 1811-1812
    • Varley, C.K.1    McClellan, J.2
  • 45
    • 67649793700 scopus 로고    scopus 로고
    • The genetic contribution to non-syndromic human obesity
    • [Review]
    • Walley, A. J., Asher, J. E., and Froguel, P. (2009). The genetic contribution to non-syndromic human obesity. Nat. Rev. Genet. 10, 431-142. [Review].
    • (2009) Nat. Rev. Genet. , vol.10 , pp. 431-142
    • Walley, A.J.1    Asher, J.E.2    Froguel, P.3
  • 47
    • 0035153224 scopus 로고    scopus 로고
    • Bodyweight gain with atypical antipsychotics. A comparative review
    • [Review]
    • Wetterling, T. (2001). Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf. 24, 59-73. [Review].
    • (2001) Drug Saf. , vol.24 , pp. 59-73
    • Wetterling, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.